Learn more about whether Blueprint Medicines Corporation or Zai Lab Limited is a better investment based on AAII's A+ ...

Zai Lab (NASDAQ:ZLAB – Get Free Report) was upgraded by stock analysts at Cantor Fitzgerald to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports. Separately ...

Updated AI-Generated Signals for Zai Lab Limited (ZLAB) available here: ZLAB.

The consensus price target hints at a 95.6% upside potential for Zai Lab Limited (ZLAB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ...

Zai Lab Limited (NASDAQ:ZLAB) today announced the promotion of Yajing Chen to Chief Financial Officer (CFO), effective July 7, 2023. Dr. Chen, currently Zai Lab’s Deputy CFO... ByInvesting.com ...

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

Investing.com - Zai Lab (NASDAQ:ZLAB) reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. Zai Lab announced ...

Zenas BioPharma Inc (Zenas), a clinical-stage global biopharmaceutical company, has outlined its significant achievements in ...